Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Orthostatic Hypotension in Individuals With Spinal Cord Injury
NCT05839652Phase 4Recruiting
- Sponsor
- James J. Peters Veterans Affairs Medical Center
- Start
- Jul 2023
- Primary completion
- Jun 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of midodrine, droxidopa in orthostatic hypotension (OH), sponsored by James J. Peters Veterans Affairs Medical Center. Started Jul 2023; status: recruiting.
02
Drugs
midodrinedroxidopa
03
Conditions
orthostatic hypotension (OH)
Beyond the preview
Go deeper on NCT05839652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05839652.